{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:14:06Z","timestamp":1740172446698,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s42000-024-00527-0","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T02:07:41Z","timestamp":1707703661000},"page":"331-338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of different starting doses of FSH on laboratory and clinical outcomes in patients with moderate AMH level"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9559-1617","authenticated-orcid":false,"given":"Minli","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengrong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"issue":"89","key":"527_CR1","first-page":"2474","volume":"5","author":"MM Reigstad","year":"2019","unstructured":"Reigstad MM, Storeng R (2019) Development of in vitro fertilization, a very important part of human reproductive medicine, in the last 40 years. Int J Womens Health Wellness 5(89):2474\u20131353","journal-title":"Int J Womens Health Wellness"},{"issue":"19","key":"527_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1008095","volume":"366","author":"MJ Davies","year":"2012","unstructured":"Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, Chan A (2012) Reproductive technologies and the risk of birth defects. New Engl J Med 366(19):1803\u20131813","journal-title":"New Engl J Med"},{"key":"527_CR3","doi-asserted-by":"publisher","unstructured":"Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA (2012) National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med 9(12):e1001356https:\/\/doi.org\/10.1371\/journal.pmed.1003292","DOI":"10.1371\/journal.pmed.1003292"},{"issue":"6","key":"527_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/humupd\/dmv042","volume":"21","author":"D Sakkas","year":"2015","unstructured":"Sakkas D, Ramalingam M, Garrido N, Barratt CL (2015) Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? Hum Reprod Update 21(6):711\u2013726","journal-title":"Hum Reprod Update"},{"key":"527_CR5","doi-asserted-by":"publisher","unstructured":"ESHRE Guideline Group on Ovarian Stimulation, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, ... Broekmans F (2020) ESHRE guideline: ovarian stimulation for IVF\/ICSI. Hum Reprod Open 2:hoaa009https:\/\/doi.org\/10.1093\/hropen\/hoaa009","DOI":"10.1093\/hropen\/hoaa009"},{"issue":"1","key":"527_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12958-021-00744-x","volume":"19","author":"H Fatemi","year":"2021","unstructured":"Fatemi H, Bilger W, Denis D et al (2021) Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007\u20132017). Reprod Biol Endocrinol 19(1):68. https:\/\/doi.org\/10.1186\/s12958-021-00744-x","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"527_CR7","first-page":"159","volume":"31","author":"R Fanchin","year":"2019","unstructured":"Fanchin R, Schon\u00e4uer LM (2019) AMH and ovarian reserve. Curr Opin Obstet Gynecol 31(3):159\u2013164","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"11","key":"527_CR8","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","volume":"105","author":"LME Moolhuijsen","year":"2020","unstructured":"Moolhuijsen LME, Visser JA (2020) Anti-M\u00fcllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function. J Clin Endocrinol Metab 105(11):3361\u20133373. https:\/\/doi.org\/10.1210\/clinem\/dgaa513","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"527_CR9","first-page":"1","volume":"134","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R, Sharpe RM (2007) Assessment of ovarian reserve. Reproduction 134(2):1\u201311","journal-title":"Reproduction"},{"issue":"4","key":"527_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.fertnstert.2018.04.039","volume":"110","author":"NP Polyzos","year":"2018","unstructured":"Polyzos NP, Drakopoulos P, Parra J, Pellicer A, Santos-Ribeiro S, Tournaye H (2018) Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including ~15,000 women. Fertil Steril 110(4):661\u2013670","journal-title":"Fertil Steril"},{"issue":"1","key":"527_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-9-82","volume":"9","author":"E Bosch","year":"2011","unstructured":"Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remoh\u00ed J (2011) Highly individualized IVF protocols are associated with an increased reproductive outcome. Reprod Biol Endocrinol 9(1):1\u20137","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"527_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/humrep\/deaa295","volume":"36","author":"MAQ Mutsaerts","year":"2021","unstructured":"Mutsaerts MAQ, Groen H, van der Veen F, Repping S, Broekmans FJM, Mol BWJ, van Wely M, OPTIFAST-1 Study Group (2021) Personalised versus standard dosing of follitropin alfa in women undergoing IVF\/ICSI: the Optimizing Follitropin alfa Dosing (OPTIFAST-1) trial. Hum Reprod 36(1):38\u201349. https:\/\/doi.org\/10.1093\/humrep\/deaa295","journal-title":"Hum Reprod"},{"issue":"1","key":"527_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-017-0252-8","volume":"15","author":"A La Marca","year":"2017","unstructured":"La Marca A, Sunkara SK, Seed PT (2017) Anti-Mullerian hormone in reproductive medicine: a review. Reprod Biol Endocrinol 15(1):1\u201319. https:\/\/doi.org\/10.1186\/s12958-017-0252-8","journal-title":"Reprod Biol Endocrinol"},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2017.00141","volume":"8","author":"C Alviggi","year":"2017","unstructured":"Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, Castaldo E (2017) Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker\u2014the follicle-to-oocyte (FOI) index. Front Endocrinol (Lausanne) 8:1\u201313. https:\/\/doi.org\/10.3389\/fendo.2017.00141","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"527_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-017-0259-1","volume":"15","author":"B Popovic-Todorovic","year":"2017","unstructured":"Popovic-Todorovic B, Puchner R, Schmidt A, Obruca A, Ott J, Ziehr S (2017) Anti-M\u00fcllerian hormone and follicle-stimulating hormone starting doses: a retrospective study on their effect on controlled ovarian hyperstimulation. Reprod Biol Endocrinol 15(1):1\u20138. https:\/\/doi.org\/10.1186\/s12958-017-0259-1","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"527_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-018-0405-7","volume":"11","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang C, Wang J, Wu X, Li H, Li Y (2018) Optimal starting dose of recombinant follicle-stimulating hormone for ovarian stimulation in women with anti-M\u00fcllerian hormone levels of 1\u20135 ng\/mL: a systematic review and meta-analysis. J Ovarian Res 11(1):1\u20139. https:\/\/doi.org\/10.1186\/s13048-018-0405-7","journal-title":"J Ovarian Res"},{"issue":"1","key":"527_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13048-017-0348-y","volume":"10","author":"Y Tang","year":"2017","unstructured":"Tang Y, Li J, Li L, Fan Z, Liang X (2017) The optimal starting dose of recombinant follicle stimulating hormone for controlled ovarian stimulation in patients with anti-M\u00fcllerian hormone levels between 1 and 5 ng\/mL. J Ovarian Res 10(1):1\u20137. https:\/\/doi.org\/10.1186\/s13048-017-0348-y","journal-title":"J Ovarian Res"},{"issue":"1","key":"527_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24403-8","volume":"8","author":"YJ Chen","year":"2018","unstructured":"Chen YJ, Wang CW, Lee TH (2018) High versus low dose of initial follicle-stimulating hormone in the long gonadotrophin-releasing hormone agonist protocol for in vitro fertilization: a randomized controlled trial. Sci Rep 8(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-018-24403-8","journal-title":"Sci Rep"},{"key":"527_CR19","doi-asserted-by":"crossref","unstructured":"Youssef MA, Van der Veen F, Al\u2010Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, ... van Wely M (2011) Gonadotropin\u2010releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev 1:CD008046","DOI":"10.1002\/14651858.CD008046.pub3"},{"key":"527_CR20","doi-asserted-by":"publisher","unstructured":"Al\u2010Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ (2016) Gonadotrophin\u2010releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev\u00a04(4):CD001750.\u00a0https:\/\/doi.org\/10.1002\/14651858.CD001750.pub4","DOI":"10.1002\/14651858.CD001750.pub4"},{"issue":"12","key":"527_CR21","first-page":"e19487","volume":"99","author":"YH Chen","year":"2020","unstructured":"Chen YH, Hwang JL, Lin YH et al (2020) Effects of different starting doses of follicle-stimulating hormone for ovarian stimulation in polycystic ovary syndrome patients undergoing in vitro fertilization and embryo transfer: A systematic review and meta-analysis. Medicine (Baltimore) 99(12):e19487","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"527_CR22","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N et al (2011) Association between the number of eggs and live birth in IVF treatment: an analysis of 400,135 treatment cycles. Hum Reprod 26(7):1768\u20131774. https:\/\/doi.org\/10.1093\/humrep\/der106","journal-title":"Hum Reprod"},{"issue":"12","key":"527_CR23","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1093\/humrep\/dex327","volume":"32","author":"TC Van Tilborg","year":"2017","unstructured":"Van Tilborg TC, Oudshoorn SC, Eijkemans MJC et al (2017) Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT Part 2: The predicted hyper responder. Hum Reprod 32(12):2506\u20132514. https:\/\/doi.org\/10.1093\/humrep\/dex327","journal-title":"Hum Reprod"},{"issue":"3","key":"527_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/GCO.0b013e32832b74a2","volume":"21","author":"EM Kolibianakis","year":"2009","unstructured":"Kolibianakis EM, Venetis CA, Tarlatzis BC (2009) The use of recombinant follicle-stimulating hormone in ovulation induction. Curr Opin Obstet Gynecol 21(3):214\u2013219. https:\/\/doi.org\/10.1097\/GCO.0b013e32832b74a2","journal-title":"Curr Opin Obstet Gynecol"},{"key":"527_CR25","doi-asserted-by":"publisher","first-page":"CD01269","DOI":"10.1002\/14651858.CD012693.pub2","volume":"2","author":"SF Lensen","year":"2018","unstructured":"Lensen SF, Wilkinson J, Leijdekkers JA, La Marca A, Mol BW, Marjoribanks J (2018) Individualized follicle-stimulating hormone dosing versus standard dosing protocols in assisted reproductive technology. Cochrane Database Syst Rev 2:CD01269. https:\/\/doi.org\/10.1002\/14651858.CD012693.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00527-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00527-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T02:17:53Z","timestamp":1719973073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00527-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00527-0","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"type":"print","value":"1109-3099"},{"type":"electronic","value":"2520-8721"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"8 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was a retrospective study and the hospital agreed to waive ethics approval and informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}